Luminopia

📍 Cambridge, United States🗓 Founded 2016👥 32 employees💰 Last funded Oct 2022
Biotechnology🌐 luminopia.com
Website LinkedIn
Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Luminopia?
Luminopia has 1 investors on record on gritt.io and 1 late-stage investors.
When did Luminopia last raise funding?
The most recent investment in Luminopia recorded on gritt.io was in October 2022.
When was Luminopia founded?
Luminopia was founded in 2016.
What industry is Luminopia in?
Luminopia operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Luminopia based?
Luminopia is headquartered in Cambridge, United States.